2025-01-01 2025-12-31 false Capium Accounts Production 1.1 03616847 2025-01-01 2025-12-31 03616847 bus:FullAccounts 2025-01-01 2025-12-31 03616847 bus:FRS102 2025-01-01 2025-12-31 03616847 bus:Audited 2025-01-01 2025-12-31 03616847 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 03616847 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 03616847 2025-01-01 2025-12-31 03616847 2025-12-31 03616847 bus:RegisteredOffice 2025-01-01 2025-12-31 03616847 core:WithinOneYear 2025-12-31 03616847 core:AfterOneYear 2025-12-31 03616847 1 2025-01-01 2025-12-31 03616847 bus:Director1 2025-01-01 2025-12-31 03616847 bus:Director1 2025-12-31 03616847 bus:Director1 2024-01-01 2024-12-31 03616847 2024-01-01 03616847 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 03616847 2024-01-01 2024-12-31 03616847 2024-12-31 03616847 core:WithinOneYear 2024-12-31 03616847 core:AfterOneYear 2024-12-31 03616847 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 03616847 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 03616847 bus:OrdinaryShareClass1 2025-12-31 03616847 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 03616847 bus:OrdinaryShareClass1 2024-12-31 03616847 core:PlantMachinery 2025-01-01 2025-12-31 03616847 core:PlantMachinery 2025-12-31 03616847 core:PlantMachinery 2024-12-31 03616847 core:MotorCars 2025-01-01 2025-12-31 03616847 core:MotorCars 2025-12-31 03616847 core:MotorCars 2024-12-31 03616847 core:FurnitureFittings 2025-01-01 2025-12-31 03616847 core:FurnitureFittings 2025-12-31 03616847 core:FurnitureFittings 2024-12-31 03616847 core:ComputerEquipment 2025-01-01 2025-12-31 03616847 core:ComputerEquipment 2025-12-31 03616847 core:ComputerEquipment 2024-12-31 03616847 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 03616847 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 03616847 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 03616847 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 03616847 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 03616847 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 03616847 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 03616847 core:Non-currentFinancialInstruments 2025-12-31 03616847 core:Non-currentFinancialInstruments 2024-12-31 03616847 core:ShareCapital 2025-12-31 03616847 core:ShareCapital 2024-12-31 03616847 core:RetainedEarningsAccumulatedLosses 2025-12-31 03616847 core:RetainedEarningsAccumulatedLosses 2024-12-31 03616847 dpl:Item1 2025-01-01 03616847 dpl:Item1 2025-12-31 03616847 dpl:Item1 2024-01-01 03616847 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 03616847
England and Wales

 

 

 

MEDISO MEDICAL IMAGING SYSTEMS UK LIMITED



Financial Statements
 


Period of accounts

Start date: 01 January 2025

End date: 31 December 2025
Director Peter Katona
Registered Number 03616847
Registered Office Arena Offices, Abbey House
282 Farnborough Road
Farnborough
GU14 7NA
Auditors Shorts Chartered Accountants
Cedar House
63 Napier Street
Sheffield
S11 8HA
Bankers National Westminster Bank Plc



1
 
 
Notes
 
31/12/2025
£
  31/12/2024
£
Fixed assets      
Tangible fixed assets 4 10,033    24,173 
10,033    24,173 
Current assets      
Stocks 5 6,307    8,162 
Debtors: amounts falling due within one year 6 267,579    683,915 
Cash at bank and in hand 755,952    863,101 
1,029,838    1,555,178 
Creditors: amount falling due within one year 7 (385,337)   (786,127)
Net current assets 644,501    769,051 
 
Total assets less current liabilities 654,534    793,224 
Creditors: amount falling due after more than one year 8 (158,068)   (311,208)
Net assets 496,466    482,016 
 

Capital and reserves
     
Called up share capital 9 1,000    1,000 
Profit and loss account 495,466    481,016 
Shareholders' funds 496,466    482,016 
 


These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 26 March 2026 and were signed by:


-------------------------------
Peter Katona
Director
2
General Information
MEDISO MEDICAL IMAGING SYSTEMS UK LIMITED  is a private company, limited by shares, registered in England and Wales.  The company's registered number is 03616847, and its registered address is Arena Offices, Abbey House, 282 Farnborough Road, Farnborough, GU14 7NA.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Turnover
Sale of goods
Turnover from the sale of goods is recognised when all of the following conditions are satisfied:
- the Company has transferred the significant risks and rewards of ownership to the buyer;
- the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the transaction; and
- the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services
Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the profit and loss account.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The companys liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and machinery 25% Straight Line
Motor Vehicles 25% Straight Line
Fixtures and Fittings 25% Straight Line
Computer Equipment 25% Straight Line
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 5 (2024 : 5).
3.

Audit Information


The auditor's report on the financial statements for the year ended 31 December 2025 was unqualified.

The auditor's report was signed by Malcolm Pope (Senior Statutory Auditor) for and on behalf of Shorts Chartered Accountants Chartered Accountants and Registered Auditor on 26 March 2026.
4.

Tangible fixed assets

Cost or valuation Plant and machinery   Motor Vehicles   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £   £
At 01 January 2025 4,300    52,505    17,354    10,603    84,762 
Additions       709    709 
Disposals (3,938)     (14,035)   (5,688)   (23,661)
At 31 December 2025 362    52,505    3,319    5,624    61,810 
Depreciation
At 01 January 2025 4,300    32,190    15,119    8,980    60,589 
Charge for year   13,126    777    945    14,848 
On disposals (3,938)     (14,035)   (5,687)   (23,660)
At 31 December 2025 362    45,316    1,861    4,238    51,777 
Net book values
Closing balance as at 31 December 2025   7,189    1,458    1,386    10,033 
Opening balance as at 01 January 2025   20,315    2,235    1,623    24,173 


5.

Stocks

31/12/2025
£
  31/12/2024
£
Stocks 6,307    8,162 
6,307    8,162 

6.

Debtors: amounts falling due within one year

31/12/2025
£
  31/12/2024
£
Trade Debtors 120,173    493,093 
Prepayments & Accrued Income 108,235    178,756 
Other Debtors 18,791    12,066 
Directors' Current Accounts 20,380   
267,579    683,915 
Included within Prepayments & Accrued Income above are £67,579 (2024: £108,016) falling due after a year.

7.

Creditors: amount falling due within one year

31/12/2025
£
  31/12/2024
£
Trade Creditors 9,332    24,751 
Amounts Owed to Group Undertakings 3,051    281,394 
Corporation Tax 6,778    13,965 
PAYE & Social Security 37,606    22,894 
Accruals & Deferred Income 327,095    398,515 
VAT 1,475    44,608 
385,337    786,127 

8.

Creditors: amount falling due after more than one year

31/12/2025
£
  31/12/2024
£
Accruals & Deferred Income 158,068    311,208 
158,068    311,208 

9.

Share Capital

Allotted, called up and fully paid
31/12/2025
£
  31/12/2024
£
100,000 Class A shares of £0.01 each 1,000    1,000 
1,000    1,000 

10.

Controlling party

The immediate and ultimate parent undertaking is Mediso Medical Imaging Systems Kft, whose registered office address is H-1037, Laborc Utca 3, Budapest, Hungary. The group financial statements of Mediso Medical Imaging Systems Kft are publicly available. 
The company has taken the available exemptions within FRS102 whereby it has not disclosed transactions with its parent company and any wholly owned subsidiaries within that group.



11.

Pension Commitments

The Company operates a defined benefit pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered scheme. The pension cost charge represents contributions payable by the Company to the fund and amounted to £16,940 (2024: £10,483). No contributions were payable to the fund at the balance sheet date in either the current or the prior year.
3